Literature DB >> 7678508

Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications.

T Papayannopoulou1, M Brice, C A Blau.   

Abstract

Although the proliferative effects of hematopoietic cytokines on erythroid progenitors are well known, parameters that influence the initiation of expression of specialized or lineage-restricted genes are not clear. We have studied the acquisition of erythroid-differentiative features from enriched populations of human early erythroid progenitors (burst-forming unit-erythroid [BFUe]) in suspension culture and the influence of several cytokines on this process. In suspension cultures containing no erythropoietin (Epo), we have found that kit ligand (KL) in synergy with interleukin-3 not only increases the proliferation of cells and of progenitors but also consistently amplifies a population of cells that contain globin within 1 week. Our experiments suggest that neither extraneously provided nor endogenously produced Epo is critical for the generation of globin-synthesizing cells. Globin-producing cells generated mostly from late BFUe or pre-CFUe with a CD34-/EP-1+ phenotype in this system do not all express a well-coordinated erythroid program accompanied by heme or glycophorin A expression and most die maintaining an immature state. Therefore, conditions that are responsible for initiation of globin expression in these cells are not sufficient to carry them to terminal maturation. The data point to an expanded target cell population for KL, as they suggest an influence of KL on survival and/or amplification of late erythroid cells previously thought to be influenced only by Epo. Our results in aggregate are of relevance to the physiology of normal erythropoiesis and the role of Epo and KL in the initial stages of lineage-restricted gene expression. In addition, they provide insight into the understanding of anemia in W and Steel mutants in which expansion of the late erythroid progenitor pool, normally dependent on the synergistic action of KL and Epo, is curtailed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678508

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors:  Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

Review 2.  Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.

Authors:  Brian M Dulmovits; Jimmy Hom; Anupama Narla; Narla Mohandas; Lionel Blanc
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

3.  Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.

Authors:  Aaron Yun Chen; Wuxiang Guan; Sai Lou; Zhengwen Liu; Steve Kleiboeker; Jianming Qiu
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells.

Authors:  S Ghaffari; H Wu; M Gerlach; Y Han; H F Lodish; G Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

Authors:  Valter Agosti; Vinit Karur; Pradeep Sathyanarayana; Peter Besmer; Don M Wojchowski
Journal:  Exp Hematol       Date:  2008-12-18       Impact factor: 3.084

6.  Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production.

Authors:  Argirios E Tsantes; Stergios T Tassiopoulos; Stefanos I Papadhimitriou; Stefanos Bonovas; Nikolaos Poulakis; Athina Vlachou; Kalitsa Filioussi; Dimitrios Loukopoulos
Journal:  Eur J Clin Pharmacol       Date:  2003-08-05       Impact factor: 2.953

Review 7.  Recent Advances in Replication and Infection of Human Parvovirus B19.

Authors:  Safder S Ganaie; Jianming Qiu
Journal:  Front Cell Infect Microbiol       Date:  2018-06-05       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.